Net gamma exposure for ADMA Biologics Inc (ADMA) options was positive at the Nov 4, 2026 close, about $410.52K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for ADMA, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for ADMA, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for ADMA, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
ADMA Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is ADMA gamma exposure positive or negative?
ADMA Biologics net gamma exposure was positive on Nov 4, 2026, at $410.52K. It has been positive on 20 of the last 20 trading days.
How has ADMA gamma exposure changed recently?
ADMA Biologics net gamma exposure went from $462.97K on Oct 7, 2026 to $410.52K on Nov 4, 2026. See the ADMA gamma exposure history for a longer view.
What is ADMA Biologics Inc?
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.